Skip to content
  • Reata Pharmaceuticals, Inc. 


    frank Avatar

    About the Author

    (RETA) DEADLINE: Did You Suffer a Substantial Loss? Contact Johnson Fistel About Leading Reata Class Action Lawsuit SAN DIEGO- Globe Newswire—December 20, 2021 Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of Reata Pharmaceuticals, Inc. (“Reata” or the “Company”) (NASDAQ: RETA). The class action is on behalf of…

    Reata Pharmaceuticals, Inc. 

    (NASDAQ: RETA)

    (RETA) DEADLINE: Did You Suffer a Substantial Loss? Contact Johnson Fistel About Leading Reata Class Action Lawsuit SAN DIEGO- Globe Newswire—December 20, 2021 Shareholder…

    • Ticker: NASDAQ: RETA
    • Lead Plaintiff Deadline:

  • Arrival SA


    frank Avatar

    About the Author

    (ARVL) DEADLINE: Did You Suffer a Substantial Loss? Contact Johnson Fistel About Leading Arrival Class Action Lawsuit SAN DIEGO- Globe Newswire—December 22, 2021 Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of Arrival SA (“Arrival” or “Company”) (NASDAQ: ARVL). The class action is on behalf of shareholders who…

    Reata Pharmaceuticals, Inc. 

    (NASDAQ: RETA)

    (RETA) DEADLINE: Did You Suffer a Substantial Loss? Contact Johnson Fistel About Leading Reata Class Action Lawsuit SAN DIEGO- Globe Newswire—December 20, 2021 Shareholder…

    • Ticker: NASDAQ: RETA
    • Lead Plaintiff Deadline:

  • Chegg, Inc.


    frank Avatar

    About the Author

    Johnson Fistel, LLP Announces That It Has Filed a Class Action Lawsuit on Behalf of Chegg Investors Alleging Violations of the Federal Securities Laws   SAN DIEGO, December 22, 2021 / (Globe Newswire)   Shareholder rights law firm Johnson Fistel, LLP announces that it has filed a class-action lawsuit on behalf of all those who…

    Reata Pharmaceuticals, Inc. 

    (NASDAQ: RETA)

    (RETA) DEADLINE: Did You Suffer a Substantial Loss? Contact Johnson Fistel About Leading Reata Class Action Lawsuit SAN DIEGO- Globe Newswire—December 20, 2021 Shareholder…

    • Ticker: NASDAQ: RETA
    • Lead Plaintiff Deadline:

  • DocuSign, Inc.


    frank Avatar

    About the Author

    (DOCU) DEADLINE: Did You Suffer a Substantial Loss? Contact Johnson Fistel About Leading DocuSign Class Action Lawsuit SAN DIEGO- Globe Newswire—December 22, 2021 Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of DocuSign, Inc. (NASDAQ: DOCU). The class action is on behalf of shareholders who purchased DocuSign securities…

    Reata Pharmaceuticals, Inc. 

    (NASDAQ: RETA)

    (RETA) DEADLINE: Did You Suffer a Substantial Loss? Contact Johnson Fistel About Leading Reata Class Action Lawsuit SAN DIEGO- Globe Newswire—December 20, 2021 Shareholder…

    • Ticker: NASDAQ: RETA
    • Lead Plaintiff Deadline:

  • Paysafe Limited


    frank Avatar

    About the Author

    SAN DIEGO, November 11, 2021 /Globe Newswire/ —  Shareholder Rights Law Firm Johnson Fistel, LLP is investigating potential claims against Paysafe Limited (“Paysafe”) (NYSE: PSFE) and its officers and directors for violations of federal securities laws. On March 30, 2021, Paysafe merged with Foley Trasimene Acquisition Corp. II (NYSE: BFT), a special purpose acquisition company.…

    Reata Pharmaceuticals, Inc. 

    (NASDAQ: RETA)

    (RETA) DEADLINE: Did You Suffer a Substantial Loss? Contact Johnson Fistel About Leading Reata Class Action Lawsuit SAN DIEGO- Globe Newswire—December 20, 2021 Shareholder…

    • Ticker: NASDAQ: RETA
    • Lead Plaintiff Deadline:

  • Exicure Inc


    frank Avatar

    About the Author

    Please contact us if you would like more information on this lawsuit.

    Reata Pharmaceuticals, Inc. 

    (NASDAQ: RETA)

    (RETA) DEADLINE: Did You Suffer a Substantial Loss? Contact Johnson Fistel About Leading Reata Class Action Lawsuit SAN DIEGO- Globe Newswire—December 20, 2021 Shareholder…

    • Ticker: NASDAQ: RETA
    • Lead Plaintiff Deadline:

  • Lightspeed Commerce Inc.


    frank Avatar

    About the Author

    Please contact us if you would like more information on this lawsuit.

    Reata Pharmaceuticals, Inc. 

    (NASDAQ: RETA)

    (RETA) DEADLINE: Did You Suffer a Substantial Loss? Contact Johnson Fistel About Leading Reata Class Action Lawsuit SAN DIEGO- Globe Newswire—December 20, 2021 Shareholder…

    • Ticker: NASDAQ: RETA
    • Lead Plaintiff Deadline:

  • Cloopen Group Holding Limited


    frank Avatar

    About the Author

    SAN DIEGO, December 10, 2021 / (Globe Newswire)   Shareholder rights law firm Johnson Fistel, LLP announces that it has filed a class action lawsuit on behalf of a class of all persons who: (a) purchased or otherwise acquired Cloopen Group Holding Limited (NYSE: RAAS) (“Cloopen” or the “Company”) American Depositary Shares (“ADSs”) pursuant and/or traceable to…

    Reata Pharmaceuticals, Inc. 

    (NASDAQ: RETA)

    (RETA) DEADLINE: Did You Suffer a Substantial Loss? Contact Johnson Fistel About Leading Reata Class Action Lawsuit SAN DIEGO- Globe Newswire—December 20, 2021 Shareholder…

    • Ticker: NASDAQ: RETA
    • Lead Plaintiff Deadline:

  • Alfi, Inc.


    frank Avatar

    About the Author

    Please contact us if you would like more information on this lawsuit.

    Reata Pharmaceuticals, Inc. 

    (NASDAQ: RETA)

    (RETA) DEADLINE: Did You Suffer a Substantial Loss? Contact Johnson Fistel About Leading Reata Class Action Lawsuit SAN DIEGO- Globe Newswire—December 20, 2021 Shareholder…

    • Ticker: NASDAQ: RETA
    • Lead Plaintiff Deadline:

  • IQIYI Inc.


    frank Avatar

    About the Author

    Please contact us if you would like more information on this lawsuit.

    Reata Pharmaceuticals, Inc. 

    (NASDAQ: RETA)

    (RETA) DEADLINE: Did You Suffer a Substantial Loss? Contact Johnson Fistel About Leading Reata Class Action Lawsuit SAN DIEGO- Globe Newswire—December 20, 2021 Shareholder…

    • Ticker: NASDAQ: RETA
    • Lead Plaintiff Deadline: